Market Share of Synthetic Biology Industry
The synthetic biology market is moderately consolidated in nature due to the presence of a few companies operating globally as well as regionally. The competitive landscape includes an analysis of some international as well as local companies that hold market shares and are well known, including Genscript, Thermo Fisher Scientific Inc., Amyris Inc., Danaher Corporation (Integrated DNA Technologies Inc.), and Illumina, Inc. Precigen Inc. (Intrexon Corporation), New England Biolabs Inc., Novozymes AS, Koninklijke DSM NV, and Viridos, Inc. (Synthetic Genomics Inc.), among others.
Synthetic Biology Market Leaders
Genscript
Thermo Fisher Scientific Inc
Amyris Inc
Integrated DNA Technologies Inc. (Danaher Corporation)
Illumina, Inc.
*Disclaimer: Major Players sorted in no particular order